NAS:BCPC Key Ratios
| Market Cap $ M | 5,688.95 |
| Enterprise Value $ M | 5,792.49 |
| P/E(ttm) | 35.06 |
| PE Ratio without NRI | 32.57 |
| Forward PE Ratio | 30.56 |
| Price/Book | 4.38 |
| Price/Sales | 5.31 |
| Price/Free Cash Flow | 33.73 |
| Price/Owner Earnings | 35.14 |
| Payout Ratio % | 0.18 |
| Revenue (TTM) $ M | 1,085.00 |
| EPS (TTM) $ | 5.09 |
| Beneish M-Score | -2.53 |
| 10-y EBITDA Growth Rate % | 6.60 |
| 5-y EBITDA Growth Rate % | 9.40 |
| y-y EBITDA Growth Rate % | 12.70 |
| EV-to-EBIT | 26.16 |
| EV-to-EBITDA | 21.50 |
| PEG | 3.46 |
| Shares Outstanding M | 31.88 |
| Net Margin (%) | 15.14 |
| Operating Margin % | 20.42 |
| Pre-tax Margin (%) | 19.56 |
| Quick Ratio | 1.56 |
| Current Ratio | 2.66 |
| ROA % (ttm) | 9.78 |
| ROE % (ttm) | 12.82 |
| ROIC % (ttm) | 11.53 |
| Dividend Yield % | 0.54 |
| Altman Z-Score | 11.19 |
BCPC Number of Guru Trades
BCPC Volume of Guru Trades
Gurus Latest Trades with NAS:BCPC
NAS:BCPC is held by these investors
Balchem Corp Insider Transactions
Guru Commentaries on NAS:BCPC
Balchem Corp. (BCPC) develops specialty ingredients for the nutrition, food, and healthcare markets. The stock underperformed despite another quarter of solid financial results as investors focused on the potential for higher costs associated with ongoing macroeconomic uncertainty. However, the fundamentals supporting our investment thesis remain intact, led by BCPC's leadership in niche markets and long history of consistent execution. We believe the company's strong competitive position and the robust demand environment will strengthen its market share over the long term.
Balchem Corp. (BCPC) develops specialty ingredients for the nutrition, food, and healthcare markets. The stock underperformed despite another quarter of solid financial results as investors focused on the potential for higher costs associated with the war in the Gulf. While first quarter sales increased 8%, management's elevated expectations left little room for upside despite continued strong execution. The fundamentals supporting our investment thesis remain intact, led by BCPC's leadership in niche markets and long history of consistent execution.
Balchem Corp. (BCPC) continues to demonstrate a durable business model with steady growth across its segments. The company is well-aligned with 'better-for-you' consumer trends, which has supported consistent earnings growth, with net income increasing nearly 17%. In a more uncertain market, investors are drawn to BCPC's ability to compound earnings with relatively low volatility, making it an attractive holding. The quarter highlighted the resilience of its operations and the favorable mix contributing to its performance.
News about NAS:BCPC
Total 0- 1